Input | Value | Year | Source |
Anti-HCV Prevalence | 8.2% | 2002 | [5] |
Viremic Rate | 77.5% | 2016 | Expert Input |
Genotype Distribution | 0.6% G1a, 5.0% G1other, 0.0% G2, 1.7% G3, 92.7% G4 | 2014 | [10] |
Previously Diagnosed (Viremic) | 19,500 | 2010 | Expert Input |
Annual Number Treated | 1200 | 2017 | Expert input |
Annual Liver Transplants | 0 | 2011 | [11] |